Form 4 for ASMB ASSEMBLY BIOSCIENCES, INC.
Accepted 2024-04-02 00:00:00 ET · period of report 2024-03-29 · accession 0000950170-24-040180 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-02 | 2024-03-29 | ASMB | Bjorkquist Jeanette M | Principal Accounting Off | A - Grant | $0.00 | +850 | 3,280 | +35% | $0 |
| D | 2024-04-02 | 2024-04-01 | ASMB | Bjorkquist Jeanette M | Principal Accounting Off | S - Sale | $13.07 | -114 | 3,166 | -3% | -$1,490 |
| D | 2024-04-02 | 2024-03-29 | ASMB | Bjorkquist Jeanette M | Principal Accounting Off | A - Grant | $0.00 | +1,550 | 1,550 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-29 | A | A | 850 | $0.00 | 3,280 | D | — | — | (F1) Grant of restricted stock units. The restricted stock units vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2025; March 29, 2026; March 29, 2027; and March 29, 2028. (F2) Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9. |
| 2 | Common | Common Stock | 2024-04-01 | S | D | 114 | $13.07 | 3,166 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. |
| 3 | Derivative | Stock Option (right to buy) | 2024-03-29 | A | A | 1,550 | $0.00 | 1,550 | D | $13.30 · — to 2034-03-29 | 1,550 Common Stock | (F5) Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2025; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2028. |